Company intelligence / Profile preview

Novameat

Barcelona, Catalonia, Spainnovameat.com ↗

Ownership: Private
Development stage: Commercial

Overview

Novameat has successfully commercialized its proprietary 3D printing and MicroForce technologies to produce plant-based meat alternatives with realistic fibrous textures. The company has launched products such as Shredded Nova-b*ef and continues to expand its product portfolio across Europe. No clinical results are relevant as it does not develop therapeutics.

Industry: Food & Nutrition

Drug pipeline

4 assets

Pulled Nova-chicken

Commercial

3 more assets in the full pipeline.

Request access →

Partnerships

Unovis Asset Management/Praesidium/Rubio Impact Ventures/Sofinnova Partners/Forbion BioEconomy Fund

Beyond the preview

Go deeper on Novameat.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novameat.

Explore the full profile